Latest News On U.S. Congress

Latest California Healthline Stories

KHN’s ‘What the Health?’: Much Ado About (Vaccine) Mandates

The fight over covid vaccines continues to intensify, with Republicans on Capitol Hill pushing — with some success — to cancel President Joe Biden’s “test regularly or vaccinate” requirement for private employers. Meanwhile, abortion is not the only health issue before the Supreme Court this term. Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat News join KHN’s Julie Rovner to discuss these issues and more.

KHN’s ‘What the Health?’: Roe v. Wade on the Rocks

A Supreme Court majority appears ready to overturn nearly 50 years of abortion rights, at least judging by the latest round of oral arguments before the justices. And a new covid variant, omicron, gains attention as it spreads around the world. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet and Shefali Luthra of The 19th join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Blake Farmer of Nashville Public Radio about the latest KHN-NPR “Bill of the Month” episode.

KHN’s ‘What the Health?’: The Big Biden Budget Bill Passes the House

President Joe Biden’s social spending budget is on its way to the U.S. Senate, where Democratic leaders are (optimistically) hoping to complete work by the end of the year. Meanwhile, covid is surging again in parts of the country, along with the political divides it continues to cause. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and the Johns Hopkins School of Public Health, and Mary Agnes Carey of KHN join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner previews next week’s Supreme Court abortion oral arguments with Florida State University law professor Mary Ziegler.

KHN’s ‘What the Health?’: Boosting Confusion

Federal health officials appear poised to extend a recommendation for covid boosters to all adults, following moves by some governors and mayors to broaden the eligible booster pool as caseloads rise. Meanwhile, the Food and Drug Administration finally has a nominee to head the agency: former FDA chief Robert Califf. And Medicare premiums for consumers will likely rise substantially in 2022, partly due to the approval of a controversial drug to treat Alzheimer’s disease. Tami Luhby of CNN, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dan Weissmann, host of the “An Arm and a Leg” podcast.